These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7690312

  • 1. Enhanced prolactin responsiveness to galanin in patients with Cushing's disease.
    Invitti C, Pecori Giraldi F, Tagliaferri A, Scacchi M, Dubini A, Cavagnini F.
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):213-6. PubMed ID: 7690312
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.
    Leal-Cerro A, Soto A, Martínez MA, Alvarez P, Isidro L, Casanueva FF, Dieguez C, Cordido F.
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):745-9. PubMed ID: 12460324
    [Abstract] [Full Text] [Related]

  • 7. Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease.
    Grottoli S, Arvat E, Gauna C, Maccagno B, Ramunni J, Giordano R, Maccario M, Deghenghi R, Ghigo E.
    Pituitary; 1999 Nov; 2(3):197-204. PubMed ID: 11081154
    [Abstract] [Full Text] [Related]

  • 8. Decreased prolactin responsiveness to thyrotrophin-releasing hormone and metoclopramide in hyperthyroidism.
    Röjdmark S, Carlsson A.
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):221-6. PubMed ID: 2998132
    [Abstract] [Full Text] [Related]

  • 9. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Anterior pituitary responsiveness in central Cushing disease and in Cushing syndrome caused by adrenal cortex tumors, as well as in simple obesity].
    Góth M, Szabolcs I, Kovács Z, Szilágyi G.
    Orv Hetil; 1995 Jan 08; 136(2):63-6. PubMed ID: 7862432
    [Abstract] [Full Text] [Related]

  • 17. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM, Haas M, Trestian S, Zylber-Haran E, Shilo S.
    Clin Endocrinol (Oxf); 1983 Sep 08; 19(3):285-94. PubMed ID: 6414745
    [Abstract] [Full Text] [Related]

  • 18. Effects of metoclopramide on the growth hormone response to galanin in normal man.
    Giustina A, Bussi AR, Doga M, Licini M, Schettino M, Wehrenberg WB.
    Horm Metab Res; 1993 Sep 08; 25(9):489-92. PubMed ID: 7693566
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.